Aligos ALG-184-202_HBV A Randomized, Double-Blind, Active-Controlled Multicenter Phase 2 Study Evaluating the Efficacy and Safety of ALG-000184 Compared with Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg-Negative Adult
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
Aligos Therapeutics, Inc.
Start Date
October 2, 2025
End Date
May 31, 2030
Administered By
Medicine, Gastroenterology
Awarded By
Aligos Therapeutics, Inc.
Start Date
October 2, 2025
End Date
May 31, 2030